急性心力衰竭综合征中的生物标志物：更新。
Biomarkers in Acute Heart Failure Syndromes: An Update.
机构信息
Cardiovascular Medicine Department, SUNY Stony Brook Medicine, Stony Brook, NY, USA.
Division of Internal Medicine, Bronx Care Hospital Center, Bronx, NY, USA.
出版信息
Curr Cardiol Rev. 2022;18(3):e090921196330. doi: 10.2174/1573403X17666210909170415.
Abstract
Heart failure is one of the leading healthcare problems in the world. Clinical data lacks sensitivity and specificity in the diagnosis of heart failure. Laboratory biomarkers are a non-invasive method of assessing suspected decompensated heart failure. Biomarkers such as natriuretic peptides have shown promising results in the management of heart failure. The literature does not provide comprehensive guidance in the utilization of biomarkers in the setting of acute heart failure syndrome. Many conditions that manifest with similar pathophysiology as acute heart failure syndrome may demonstrate positive biomarkers. The following is a review of biomarkers in heart failure, enlightening their role in diagnosis, prognosis and management of heart failure.
摘要
心力衰竭是世界范围内主要的医疗保健问题之一。临床数据在心力衰竭的诊断中缺乏敏感性和特异性。实验室生物标志物是评估疑似心力衰竭失代偿的一种非侵入性方法。生物标志物，如利钠肽，在心衰管理中显示出有前景的结果。文献并没有在急性心力衰竭综合征的背景下提供生物标志物使用的全面指导。许多表现出与急性心力衰竭综合征相似病理生理学的病症可能显示出阳性生物标志物。以下是对心力衰竭生物标志物的综述，阐明了它们在心衰的诊断、预后和管理中的作用。
相似文献
1
Biomarkers in Acute Heart Failure Syndromes: An Update.
Curr Cardiol Rev. 2022;18(3):e090921196330. doi: 10.2174/1573403X17666210909170415.
2
Natriuretic Peptides in Clinical Practice.
Anatol J Cardiol. 2019 Mar;21(Suppl 1):1-40. doi: 10.14744/AnatolJCardiol.2019.55623.
3
Natriuretic peptides in heart failure and acute coronary syndrome.
Clin Lab Med. 2014 Mar;34(1):43-58, vi. doi: 10.1016/j.cll.2013.11.007. Epub 2014 Jan 14.
4
Natriuretic Peptides: Role in the Diagnosis and Management of Heart Failure: A Scientific Statement From the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.
J Card Fail. 2023 May;29(5):787-804. doi: 10.1016/j.cardfail.2023.02.009. Epub 2023 Apr 17.
5
Natriuretic peptides: role in the diagnosis and management of heart failure: a scientific statement from the Heart Failure Association of the European Society of Cardiology, Heart Failure Society of America and Japanese Heart Failure Society.
Eur J Heart Fail. 2023 May;25(5):616-631. doi: 10.1002/ejhf.2848. Epub 2023 Apr 26.
6
Biomarkers in acute heart failure.
Rev Esp Cardiol (Engl Ed). 2015 Jun;68(6):514-25. doi: 10.1016/j.rec.2015.02.009. Epub 2015 Apr 21.
7
[Biomarkers for the diagnosis and management of heart failure: natriuretic peptides].
G Ital Cardiol (Rome). 2021 Apr;22(4):292-300. doi: 10.1714/3574.35575.
8
Natriuretic peptide testing for heart failure therapy guidance in the inpatient and outpatient setting.
Am J Ther. 2009 Mar-Apr;16(2):171-7. doi: 10.1097/MJT.0b013e318172797f.
9
Natriuretic peptide guided heart failure management.
Curr Clin Pharmacol. 2009 May;4(2):87-94. doi: 10.2174/157488409788184945.
10
An update on utilising brain natriuretic peptide for risk stratification, monitoring and guiding therapy in heart failure.
Expert Rev Mol Diagn. 2023 Jun;23(6):521-533. doi: 10.1080/14737159.2023.2216386. Epub 2023 May 27.
引用本文的文献
1
NT-proBNP changes predict outcomes in elderly type 2 myocardial infarction patients.
BMC Geriatr. 2025 Jul 16;25(1):535. doi: 10.1186/s12877-025-06169-0.
2
Soluble CD146 in Heart Failure: Pathophysiological Role and Diagnostic Potential.
Biomedicines. 2025 Jun 3;13(6):1370. doi: 10.3390/biomedicines13061370.
3
Can Endothelin-1 Help Address the Diagnostic and Prognostic Challenges in Multimorbid Acute Heart Failure Patients?
Life (Basel). 2025 Apr 9;15(4):628. doi: 10.3390/life15040628.
4
High mRNA Expression of 24 Dehydrocholesterol Reductase (DHCR24) in the Treatment of Doxorubicin-Induced Heart Failure in Rats.
Int J Mol Sci. 2025 Jan 1;26(1):312. doi: 10.3390/ijms26010312.
5
HE4 Serum Levels are Associated with Poor Prognosis in Patients with Acute Heart Failure Combined with Chronic Kidney Disease.
Int J Gen Med. 2024 Apr 2;17:1273-1280. doi: 10.2147/IJGM.S444680. eCollection 2024.
6
Editorial: Acute heart failure: From bench to bedside.
Front Physiol. 2023 Apr 19;14:1194213. doi: 10.3389/fphys.2023.1194213. eCollection 2023.
本文引用的文献
1
Towards a multi-marker prognostic strategy in acute heart failure: a role for GDF-15.
ESC Heart Fail. 2018 Dec;5(6):1017-1022. doi: 10.1002/ehf2.12301. Epub 2018 Aug 24.
2
The Potential of Angiogenin as a Serum Biomarker for Diseases: Systematic Review and Meta-Analysis.
Dis Markers. 2018 Mar 15;2018:1984718. doi: 10.1155/2018/1984718. eCollection 2018.
3
The Burden of Iron Deficiency in Heart Failure: Therapeutic Approach.
J Am Coll Cardiol. 2018 Feb 20;71(7):782-793. doi: 10.1016/j.jacc.2017.12.027.
4
Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association.
Circulation. 2018 Mar 20;137(12):e67-e492. doi: 10.1161/CIR.0000000000000558. Epub 2018 Jan 31.
5
Heart-type fatty acid-binding protein in cardiovascular disease: A systemic review.
Clin Chim Acta. 2017 Nov;474:44-53. doi: 10.1016/j.cca.2017.09.007. Epub 2017 Sep 11.
6
Effect of Natriuretic Peptide-Guided Therapy on Hospitalization or Cardiovascular Mortality in High-Risk Patients With Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.
JAMA. 2017 Aug 22;318(8):713-720. doi: 10.1001/jama.2017.10565.
7
Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial : Differential Response in Acute Heart Failure.
Cardiovasc Drugs Ther. 2017 Jun;31(3):281-293. doi: 10.1007/s10557-017-6726-1.
8
Associations between volume status and circulating microRNAs in acute heart failure.
Eur J Heart Fail. 2017 Aug;19(8):1077-1078. doi: 10.1002/ejhf.867. Epub 2017 May 25.
9
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.
J Am Coll Cardiol. 2017 Aug 8;70(6):776-803. doi: 10.1016/j.jacc.2017.04.025. Epub 2017 Apr 28.
10
Biomarker Profiles in Heart Failure Patients With Preserved and Reduced Ejection Fraction.
J Am Heart Assoc. 2017 Mar 30;6(4):e003989. doi: 10.1161/JAHA.116.003989.
Zotero 插件